Remdesivir study finally published – ... - Lung Conditions C...

Lung Conditions Community Forum

56,315 members66,940 posts

Remdesivir study finally published – an expert in critical care medicine gives us his verdict.

2greys profile image
6 Replies

The results of the ACTT-1 trial, which looked at the effectiveness of remdesivir as a treatment for COVID-19, have finally been published. So far the only drug that has been shown to reduce deaths from the disease has been dexamethasone, a steroid that suppresses the immune system through its anti-inflammatory effects. Steroids have a secondary effect on the disease – they don’t target the virus itself. Remdesivir, on the other hand, goes straight to the cause of the disease by inhibiting the virus.

The drug, which was developed by Gilead Sciences, was approved for use by the US Food and Drug Administration under an “emergency use authorisation” on May 1. It was recently used to treat President Donald Trump.

theconversation.com/remdesi...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
6 Replies
deni-123red_ profile image
deni-123red_

Well if it was used on the POTUS the drug must be ok. That’s progress I guess but is the drug available in the UK I wonder.

Soul01 profile image
Soul01 in reply todeni-123red_

As far as I know, the Royal Free were taking part because they had used it when treating Ebola patients so I think it should be available in the U.K. but under what criteria is anyone’s guess!

deni-123red_ profile image
deni-123red_ in reply toSoul01

That’s interesting and perhaps it’s not yet been cleared to be used here yet for Covid patients. Possibly it’s in short supply too.

Thanks for the information

HungryHufflepuff profile image
HungryHufflepuff in reply todeni-123red_

This from the article: Based on these positive findings, it would be tempting to conclude that all patients who have the disease should receive the drug, but since it costs around US$2,340 (£1,795) to treat one patient, and is likely to be in short supply in the UK for the foreseeable future, the question warrants a more considered analysis.

So I guess it is in short supply in the U.K. 🤔

deni-123red_ profile image
deni-123red_ in reply toHungryHufflepuff

Yes that is a very expensive drug and unlikely to be cleared by NICE. The number of Ebola patients versus COVID patients is nowhere near comparable.

Mavary profile image
Mavary

This is why I wonder if Donald Trump really did have Covid or was it a Electoral ploy?

Not what you're looking for?

You may also like...

emphysema

GOOD NEWS FOR AS PLEASE REEDLung Damage In Emphysema Halted By Common Acne Drug Friday 16 May 2008...
123podmore profile image

Drug trials

Whilst many of us have taken part in drug trials, it seems not all outcomes are published....
Toci profile image

Spiriva respimat.

Hi all. I found this recently. It's from 2011 in the British medical journal with regards Spiriva...
Gazza01 profile image

Researchers show that certain antibiotics can prevent the entry of SARS-CoV-2 into cells.

The Drug Design and Molecular Topology Unit group of the University of Valencia has shown that...
2greys profile image

Scientists in China believe new drug can stop pandemic 'without vaccine'.

A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus...
2greys profile image

Moderation team

See all
AsthmaandLung profile image
AsthmaandLungAdministrator
moderator_AandLUK profile image
moderator_AandLUKAdministrator
Claire_ALUK profile image
Claire_ALUKAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.